热门资讯> 正文
Inspira Technology获得2250万美元的采购订单
2025-07-02 21:57
- Inspira Technologies (NASDAQ:IINN) on Wednesday announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system.
- The order was placed by a privately held company headquartered outside the United States, with a track record and active commercial ties to both government entities and institutional healthcare customers.
- Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025.
- IINN is +8.11% to $0.8798.
- Source: Press Release
More on Inspira Technologies Oxy B.H.N.
- Inspira stock soars on initiating global commercial rollout of ART100 system
- Inspira Technologies president Joe Hayon steps down
- Seeking Alpha’s Quant Rating on Inspira Technologies Oxy B.H.N.
- Historical earnings data for Inspira Technologies Oxy B.H.N.
- Financial information for Inspira Technologies Oxy B.H.N.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
